Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wolfgang Arns

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Medizinische Klinik (Munich, Germany : 1983)|October 19, 2002
[From acute to chronic rejection after kidney transplantation]Wolfgang Arns, Manfred Weber
Transplantation Reviews (Orlando, Fla.)|November 26, 2015
Everolimus immunosuppression in kidney transplantation: What is the optimal strategy?Oliver Witzke, Claudia Sommerer, Wolfgang Arns
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|March 20, 2009
Cost-effectiveness of immunosuppressive regimens in renal transplant recipients in Germany: a model approachJan Steffen Jürgensen, Wolfgang Arns, Bastian Hass
Medizinische Klinik (Munich, Germany : 1983)|June 22, 2005
[Successful treatment of a severe case of idiopathic pulmonary fibrosis with rapamycin]Lutz Buschhausen, Matthias Kamm, Wolfgang Arns, et al.
Transplantation|May 16, 2006
Patient-reported gastrointestinal symptom burden and health-related quality of life following conversion from mycophenolate mofetil to enteric-coated mycophenolate sodiumLaurence Chan, Shamkant Mulgaonkar, Rowan Walker, et al.
Transplantation Reviews (Orlando, Fla.)|July 29, 2008
Immunosuppression in renal transplantation: some aspects for the modern eraSteven Chadban, Randall Morris, Hans H Hirsch, et al.
Frontiers in Immunology|June 22, 2026
ABO-incompatible kidney transplantation with high isoagglutinin titres: practice pattern and problem solving: a German multi-centre surveyStefan Reuter, Christian Jungck, Ana Harth, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 29, 2007
Sirolimus in renal transplantationChristian Morath, Wolfgang Arns, Vedat Schwenger, et al.
Clinical Transplantation|March 3, 2005
Enteric-coated mycophenolate sodium delivers bioequivalent MPA exposure compared with mycophenolate mofetilWolfgang Arns, Stephan Breuer, Somesh Choudhury, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 21, 2004
Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patientsMaurizio Salvadori, Herwig Holzer, Angelo de Mattos, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Medizinische Klinik (Munich, Germany : 1983)|October 19, 2002
[From acute to chronic rejection after kidney transplantation]Wolfgang Arns, Manfred Weber
Transplantation Reviews (Orlando, Fla.)|November 26, 2015
Everolimus immunosuppression in kidney transplantation: What is the optimal strategy?Oliver Witzke, Claudia Sommerer, Wolfgang Arns
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|March 20, 2009
Cost-effectiveness of immunosuppressive regimens in renal transplant recipients in Germany: a model approachJan Steffen Jürgensen, Wolfgang Arns, Bastian Hass
Medizinische Klinik (Munich, Germany : 1983)|June 22, 2005
[Successful treatment of a severe case of idiopathic pulmonary fibrosis with rapamycin]Lutz Buschhausen, Matthias Kamm, Wolfgang Arns, et al.
Transplantation|May 16, 2006
Patient-reported gastrointestinal symptom burden and health-related quality of life following conversion from mycophenolate mofetil to enteric-coated mycophenolate sodiumLaurence Chan, Shamkant Mulgaonkar, Rowan Walker, et al.
Transplantation Reviews (Orlando, Fla.)|July 29, 2008
Immunosuppression in renal transplantation: some aspects for the modern eraSteven Chadban, Randall Morris, Hans H Hirsch, et al.
Frontiers in Immunology|June 22, 2026
ABO-incompatible kidney transplantation with high isoagglutinin titres: practice pattern and problem solving: a German multi-centre surveyStefan Reuter, Christian Jungck, Ana Harth, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 29, 2007
Sirolimus in renal transplantationChristian Morath, Wolfgang Arns, Vedat Schwenger, et al.
Clinical Transplantation|March 3, 2005
Enteric-coated mycophenolate sodium delivers bioequivalent MPA exposure compared with mycophenolate mofetilWolfgang Arns, Stephan Breuer, Somesh Choudhury, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 21, 2004
Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patientsMaurizio Salvadori, Herwig Holzer, Angelo de Mattos, et al.
Pageof 6